Sign In
Buy EYPT
$12.25
-0.610 (-4.74%)
At Close: Jul 31, 2026
- No unexpected safety findings during the course of the study -
Where Do Hedge Funds Stand On EyePoint Pharmaceuticals, Inc. (EYPT)?
09:13am, Wednesday, 25'th Nov 2020
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors
EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD on December 4
07:00am, Thursday, 19'th Nov 2020
WATERTOWN, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products,
EyePoint Pharmaceuticals Announces Presentations at the Upcoming American Academy of Ophthalmology 2020 Virtual Annual Meeting
07:00am, Tuesday, 10'th Nov 2020
WATERTOWN, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products,
EyePoint Pharmaceuticals, Inc.'s (EYPT) CEO Nancy Lurker on Q3 2020 Results - Earnings Call Transcript
08:37am, Sunday, 08'th Nov 2020
EyePoint Pharmaceuticals, Inc.'s (EYPT) CEO Nancy Lurker on Q3 2020 Results - Earnings Call Transcript
EyePoint Pharmaceuticals Announces Third Quarter 2020 Financial Results Release Date and Conference Call Information
07:00am, Thursday, 29'th Oct 2020
WATERTOWN, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products,
Week In Review: Innovent Out-Licenses Ex-China Rights For PD-1 To Lilly In $1 Billion Deal
08:36am, Sunday, 23'rd Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
10X Genomics Inc (NASDAQ: TXG)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Avenue Therapeutics Inc (NASDAQ: ATXI)...
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
Catalent Inc (NYSE: CTLT)
CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
Eyepoint Pharmaceuticals’ (EYPT) Hold Rating Reaffirmed at HC Wainwright
07:58am, Sunday, 09'th Aug 2020
Eyepoint Pharmaceuticals (NASDAQ:EYPT)‘s stock had its “hold” rating restated by research analysts at HC Wainwright in a note issued to investors on Thursday, TipRanks reports. EYPT has been the
EyePoint Pharmaceuticals (EYPT) Receives a Hold from H.C. Wainwright - Markets
10:42am, Thursday, 06'th Aug 2020
In a report released today, Yi Chen from H.C. Wainwright reiterated a Hold rating on EyePoint Pharmaceuticals (EYPT – Research
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Tops Revenue Estimates
01:25pm, Wednesday, 05'th Aug 2020
EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of 9.09% and 46.69%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
EyePoint Pharmaceuticals: Q4 Earnings Insights
12:19pm, Wednesday, 05'th Aug 2020
Shares of EyePoint Pharmaceuticals (NASDAQ:EYPT) moved lower by 2.5% in pre-market trading after the company reported Q4 results.Quarterly Results Earnings per share increased 9.09% year over year to
